피임약 시장 규모, 점유율, 성장 분석 : 제품별, 유통 채널별, 지역별 - 산업별 예측(2024-2031년)

Contraceptives Market size was valued at USD 28.22 billion in 2022 and is poised to grow from USD 30.31 billion in 2023 to USD 53.65 billion by 2031, growing at a CAGR of 7.40% in the forecast period (2024-2031).

The global contraceptives market is experiencing robust growth, propelled by heightened awareness of family planning, a rise in sexually transmitted infections (STIs), and an increased demand for effective contraceptive solutions. Key advancements, including long-acting reversible contraceptives (LARCs) and a diverse range of available options, are further stimulating market expansion. Government initiatives promoting reproductive health enhance market conditions. However, challenges such as social stigma, cultural barriers, and limited access in certain regions can hinder growth. Despite these obstacles, the growing focus on women's health and the broadening acceptance of contraception as a tool for empowerment are poised to foster continued growth in the global contraceptives market in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptives Market Segmental Analysis

Global Contraceptives Market is segmented by product, distribution channel and region. Based on product, the market is segmented into contraceptive drugs and contraceptive devices. Based on distribution channel, the market is segmented into healthcare facilities, pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptives Market

A major catalyst for the global contraceptives market is the rising awareness and acceptance surrounding family planning and reproductive health. As communities become more informed about the critical role of contraception in managing population growth and improving women's health, the demand for contraceptive options has surged considerably. This uptick is further bolstered by government initiatives and programs that advocate for family planning, as well as the dedicated efforts of various organizations working to enhance public understanding of contraceptive methods. Consequently, the convergence of education, policy support, and advocacy has fueled substantial growth within the contraceptives market.

Restraints in the Contraceptives Market

The global contraceptives market faces significant constraints primarily due to cultural and religious barriers that impede the acceptance and utilization of contraceptives in various regions. In many communities, prevailing cultural and religious norms discourage or outright prohibit contraceptive use, resulting in diminished adoption rates. Additionally, insufficient accessibility, particularly in rural and remote areas, compounds these challenges. Factors such as limited availability, high costs, and inadequate distribution networks further restrict access to contraceptives, especially in developing nations. Addressing these cultural and logistical obstacles is essential for fostering market expansion and achieving universal access to effective contraception methods.

Market Trends of the Contraceptives Market

The global contraceptives market is witnessing a significant trend towards the increasing adoption of long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants. These options are favored for their high efficacy and convenience, as they require minimal maintenance compared to traditional methods. As women seek reliable, hassle-free solutions, LARCs are becoming increasingly popular, reflecting a broader shift towards effective and sustainable contraceptive solutions. Technological advancements have further enhanced the appeal of LARCs, leading to the development of innovative, user-friendly products that cater to evolving consumer needs. This shift underscores a growing preference for modern contraceptive methods in the global market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Contraceptives Market Size by Product & CAGR (2024-2031)

• Market Overview
• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectables
• Contraceptive Devices
  • Condom
  • Male Condom
  • Female Condom
  • Subdermal Implants
  • Intrauterine Devices (IUDS)
  • Copper IUDS
  • Hormonal IUDS
  • Vaginal Ring
  • Diaphragm

Global Contraceptives Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Healthcare Facilities
• Pharmacies
• Others

Global Contraceptives Market Size & CAGR (2024-2031)

• North America (Product, Distribution Channel)
  • USA
  • Canada
• Europe (Product, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karex Berhad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations